Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tenaya Therapeutics
Biotech
Tenaya, Alnylam ink collab to find gene targets for cardio drugs
The agreement includes a $10 million upfront payment and much more in potential milestone payments for Tenaya if the partnership bears fruit.
Will Maddox
Mar 5, 2026 10:56am
FDA puts Tenaya heart disease gene therapy trial on hold
Nov 10, 2025 5:16am
Bolt Bio halves workforce, while Tenaya lays off 5th of staff
May 15, 2024 7:17am
Tenaya's cardiac gene therapy boosts long-term survival in mice
Mar 18, 2024 2:33pm
Tenaya tackles genetic heart disease after nailing down target
Jul 11, 2022 3:30pm
Tenaya Therapeutics decides now is the time to IPO
Jul 12, 2021 7:45am